XRCC1 and breast cancer: The results revealed that XRCC1‐Gln/Arg (AG) was the most frequent genotype with 3.1‐fold increased risk of developing BC in pre‐menopausal patients than their post‐menopausal counterparts (OR = 3.23, CI 95% = 2.08–5.02, p = 0.001).